Nevertheless, our data represents an advance in biomedical science because it shows the power of ACE2 (rs2285666) and TMPRSS2 (rs12329760) gene polymorphisms to predict COVID-19-related disease severity that, in addition to routine cell and serum markers, explains 86% of the severity. The gene discussed is ACE2; the disease is COVID-19.